Table 1. Clinical characteristics of 227 patients with HCC.
| Variables | Group 1 (CXCL17) | Group 2 (TMA) |
| Cases (n) | 227 | 101 |
| Age, years (median, range) | 51, 13–79 | 52, 23–73 |
| Gender (male/female) | 197/30 | 90/11 |
| HBsAg (negative/positive) | 18/209 | 1/100 |
| Cirrhosis (absent/present) | 85/142 | 38/63 |
| ALT (U/liter, ≤42/>42) | 138/89 | 60/41 |
| AST (U/liter, ≤42/>42) | 131/96 | 60/41 |
| AFP (ng/ml, ≤25/>25) | 78/149 | 29/72 |
| Tumor size (cm, ≤5/>5) | 96/131 | 37/64 |
| Tumor differentiation (I–II/III–IV) | 129/98 | 44/57 |
| Vascular invasion (absent/present) | 186/41 | 83/18 |
| Tumor multiplicity (solitary/multiple) | 170/57 | 71/30 |
| Capsulation (absent/present) | 52/175 | 23/78 |
| TNM stage (I–II/III–IV) | 122/105 | 51/50 |
| BCLC stage (0–A vs. B–C) | 136/91 | 57/44 |
Abbreviations: AFP: alpha-fetoprotein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; BCLC: Barcelona Clinic Liver Cancer; HBsAg: hepatitis B surface antigen; TMA: Tissue microarray; TNM: tumor-nodes-metastasis.